Revised Results for Q. E. 30-06-2024 are attached herewith after correction of minor typographical error. This will have no effect on the figures of financial results ...

Objective: Boennuokang ® leuprorelin acetate microspheres show a certain efficacy in patients with prostate cancer, but its utilization as neoadjuvant therapy in patients with high-risk prostate ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.